Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Kostner

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
European Journal of Clinical Investigation|January 27, 2006
Does lipoprotein(a) predict risk in type 2 diabetes?K M Kostner
European Journal of Clinical Investigation|December 21, 2004
Activation of the complement system: a crucial link between inflammation and atherosclerosis?K M Kostner
Wiener Medizinische Wochenschrift (1946)|July 17, 1999
[Aggressive therapy and combination therapy in severe hyperlipidemia]K M Kostner
Wiener Medizinische Wochenschrift (1946)|January 1, 1994
[Radical therapy of refractory hyperlipidemia: extracorporeal cholesterol elimination]K M Kostner
Wiener Klinische Wochenschrift|November 17, 1998
[Lowering cholesterol 1998. Cholesterol synthesis inhibitors compared]K M Kostner, G M Kostner
Handbook of Experimental Pharmacology|April 7, 2006
Therapy of hyper-Lp(a)K M Kostner, G M Kostner
European Journal of Clinical Investigation|January 1, 1997
LDL-apheresis significantly reduces urinary apo(a) excretionK M Kostner, M Jansen, G Maurer, et al.
Atherosclerosis|February 28, 1997
Urinary apo(a) discriminates coronary artery disease patients from controlsK M Kostner, K Huber, T Stefenelli, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 12, 1998
Urinary excretion of apo(a) in patients after kidney transplantationK M Kostner, R Oberbauer, U Hoffmann, et al.
Journal of Clinical Apheresis|July 29, 2005
Plasma delipidation process induces rapid regression of atherosclerosis and mobilisation of adipose tissueB E Cham, K M Kostner, T M Shafey, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
European Journal of Clinical Investigation|January 27, 2006
Does lipoprotein(a) predict risk in type 2 diabetes?K M Kostner
European Journal of Clinical Investigation|December 21, 2004
Activation of the complement system: a crucial link between inflammation and atherosclerosis?K M Kostner
Wiener Medizinische Wochenschrift (1946)|July 17, 1999
[Aggressive therapy and combination therapy in severe hyperlipidemia]K M Kostner
Wiener Medizinische Wochenschrift (1946)|January 1, 1994
[Radical therapy of refractory hyperlipidemia: extracorporeal cholesterol elimination]K M Kostner
Wiener Klinische Wochenschrift|November 17, 1998
[Lowering cholesterol 1998. Cholesterol synthesis inhibitors compared]K M Kostner, G M Kostner
Handbook of Experimental Pharmacology|April 7, 2006
Therapy of hyper-Lp(a)K M Kostner, G M Kostner
European Journal of Clinical Investigation|January 1, 1997
LDL-apheresis significantly reduces urinary apo(a) excretionK M Kostner, M Jansen, G Maurer, et al.
Atherosclerosis|February 28, 1997
Urinary apo(a) discriminates coronary artery disease patients from controlsK M Kostner, K Huber, T Stefenelli, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 12, 1998
Urinary excretion of apo(a) in patients after kidney transplantationK M Kostner, R Oberbauer, U Hoffmann, et al.
Journal of Clinical Apheresis|July 29, 2005
Plasma delipidation process induces rapid regression of atherosclerosis and mobilisation of adipose tissueB E Cham, K M Kostner, T M Shafey, et al.
Pageof 2